IMNN
Imunon Inc
NASDAQ: IMNN · HEALTHCARE · BIOTECHNOLOGY
$2.83
+5.60% today
Updated 2026-04-30
Market cap
$10.98M
P/E ratio
—
P/S ratio
17.94x
EPS (TTM)
$-6.83
Dividend yield
—
52W range
$3 – $36
Volume
0.1M
Imunon Inc (IMNN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.25M | — | $2.50M | — | — | $2.00M | — | $500000.00 | $500000.00 | $500000.00 | $500000.00 | $500000.00 | $500000.00 | $500000.00 | $500000.00 | $500000.00 | $500000.00 | $125000.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | -100.0% | — | -100.0% | — | — | -100.0% | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -75.0% | -100.0% | — |
| Cost of revenue | $6.67M | — | — | — | — | — | — | — | — | — | — | $13.08M | $11.07M | $13.07M | $11.34M | $702918.00 | $731629.00 | $720005.00 | $718116.00 | — |
| Gross profit | $4.58M | — | $2.50M | — | — | $2.00M | — | $500000.00 | $500000.00 | $500000.00 | $500000.00 | $500000.00 | $500000.00 | $500000.00 | $500000.00 | $500000.00 | $500000.00 | $-720005.00 | $-718116.00 | — |
| Gross margin | 40.7% | — | 100.0% | — | — | 100.0% | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -576.0% | — | — |
| R&D | $9.35M | $8.23M | $12.01M | $13.68M | $14.71M | $19.86M | $15.77M | $9.36M | $14.97M | $14.66M | $14.62M | $13.08M | $11.87M | $13.07M | $11.34M | $10.62M | $11.73M | $11.29M | $11.64M | $7.78M |
| SG&A | $3.72M | $5.35M | $2.04M | $3.33M | $4.92M | $5.15M | $6.37M | $6.55M | $8.86M | $6.69M | $6.53M | $5.89M | $9.70M | $8.00M | $7.64M | $10.89M | $13.69M | $9.74M | $7.49M | $6.87M |
| Operating income | $-8.49M | $-13.59M | $-11.55M | $-17.01M | $-19.64M | $-23.02M | $-22.14M | $-15.41M | $-24.72M | $-20.85M | $-20.65M | $-18.47M | $-21.07M | $-20.57M | $-18.49M | $-21.01M | $-24.92M | $-21.03M | $-19.13M | $-14.65M |
| Operating margin | -75.4% | — | -462.0% | — | — | -1150.9% | — | -3082.3% | -4943.0% | -4169.4% | -4130.0% | -3693.7% | -4213.0% | -4113.1% | -3697.3% | -4201.4% | -4984.3% | -16824.3% | — | — |
| EBITDA | $-9.84M | $-13.13M | $-11.58M | $-15.80M | $-18.61M | $-22.55M | $-21.86M | $-7.00M | $-23.80M | $-20.68M | $-20.31M | $-19.76M | $-21.23M | $-16.55M | $-21.30M | $-20.88M | $-31.71M | $-19.88M | $-17.90M | $-13.95M |
| EBITDA margin | -87.5% | — | -463.0% | — | — | -1127.6% | — | -1399.4% | -4759.7% | -4135.8% | -4061.6% | -3951.5% | -4246.7% | -3310.6% | -4259.1% | -4176.0% | -6341.0% | -15902.6% | — | — |
| EBIT | $-9.50M | $-13.09M | $-11.64M | $-15.91M | $-18.79M | $-22.72M | $-22.14M | $-7.34M | $-24.17M | $-21.10M | $-21.33M | $-20.31M | $-21.59M | $-17.27M | $-22.04M | $-21.58M | $-32.44M | $-20.60M | $-18.62M | $-14.65M |
| Interest expense | $1.10M | $49.42M | $141612.00 | $94920.00 | $31517.00 | $501855.00 | $307000.00 | $915235.00 | $1.33M | $1.36M | $722993.00 | $91756.00 | $712025.00 | $1.39M | $1.29M | $569881.00 | $5.03M | $197080.00 | $0.00 | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-7.58M | $35.35M | $-11.79M | $-15.19M | $-18.82M | $-23.22M | $-26.57M | $-8.25M | $-25.49M | $-22.46M | $-22.05M | $-20.40M | $-11.88M | $-16.85M | $-21.48M | $-20.77M | $-35.90M | $-19.51M | $-18.62M | $-14.49M |
| Net income growth (YoY) | — | +566.1% | -133.3% | -28.9% | -23.9% | -23.4% | -14.4% | +68.9% | -209.0% | +11.9% | +1.8% | +7.5% | +41.8% | -41.8% | -27.5% | +3.3% | -72.8% | +45.6% | +4.6% | +22.2% |
| Profit margin | -67.4% | — | -471.4% | — | — | -1161.1% | — | -1650.3% | -5098.9% | -4492.2% | -4410.7% | -4080.4% | -2376.7% | -3370.3% | -4296.7% | -4153.9% | -7179.6% | -15612.0% | — | — |